arrow
G

Giovanni Centonze

Department of Pathology and Laboratory Medicine
H指数:25
被引数:2,036

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids

肺神经内分泌肿瘤和类癌的深层分子谱分析

2026-08-270
OA
Digital Immunophenotyping of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Subtypes With Specific Tumor-Immune Microenvironment Features

肺不典型类癌和大细胞神经内分泌癌的数字免疫分型识别出具有特定肿瘤-免疫微环境特征的三个亚型

2025-10-240
OA
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior
2025-03-010
OAAI
CXCR4 Expression Increases in Platinum-Based Treated Non-Small Cell Lung Cancer and is Associated with a Worsening Trend in Progression Free Survival e A Clinical-Based Population Study Confirms Preclinical Models
2025-03-010
PRE
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
2024-06-011
OAAI
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives

标记无效的肺大细胞癌的两种转录组亚型的表征表明不同的起源和潜在的新治疗观点

2024-01-030
OAAI
Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoids
2023-02-215
OAAI
Prognostic Factors Across Poorly Differentiated Neuroendocrine Neoplasms: a Pooled Analysis

低分化神经内分泌肿瘤的预后因素: 一项汇总分析

2022-11-237
PRE
Lung carcinoid tumours: histology and Ki-67, the eternal rivalry
2022-10-2620
OAAI
Transcriptomic signature and immune infiltrate in metastatic collecting duct renal cell carcinoma patients treated with first-line cabozantinib: Results of exploratory endpoints from BONSAI trial (Meeturo 2)
2022-09-010
OAAI